Latest News

Stay Updated

By subscribing, you agree to receive emails from Origin. You may choose to unsubscribe at any time

Origin Therapeutics Announces New Director

Origin is pleased to announce the election of Michael Galego as a new director of the Company. Vancouver, B.C. – September 13, 2022 – Origin Therapeutics Holdings Inc. (CSE:ORIG) (the “Company” or “Origin Therapeutics”),

Read Article

Origin Therapeutics Announces Leadership Team

Vancouver, British Columbia, November 15, 2021 – Origin Therapeutics Holdings Inc. (the “Company” or “Origin Therapeutics”), an actively managed investment issuer focused on making equity investments in private, psychedelics-related companies

Read Article

Join our psychedelic-focused investment opportunity

Talk to Our Team

Want to make psychedelic therapy part of your investing strategy? Connect with our team to find out more.